Haohai Biotech repurchases shares, plans further buybacks

Shanghai Haohai Biological Technology (SSE: 688366) announced a share repurchase of 82,000 A-shares on March 5, 2025, at a cost of RMB 4,940,552.45. The shares were bought back on the Shanghai Stock Exchange at prices ranging from RMB 59.93 to RMB 60.5 per share. The company also reported changes in its H-shares (stock code: 06826) and A-shares, detailing adjustments in issued and treasury shares. Notably, the company highlighted that the percentage of issued shares (excluding treasury shares) is based on a total of 230,444,504 ordinary shares (comprising 191,302,664 A-shares and 39,141,840 H-shares). The announcement confirms compliance with listing rules and outlines previous uncancelled repurchases from December 2024 and January 2025. Haohai Biotech affirmed that the buyback adheres to exchange regulations.